Baek et al reported a model for predicting the risk of relapse for a patient with Graves' disease. This can help to identify a patient who may require more aggressive management. The authors are from the Catholic University of Korea and multiple associated hospitals.
Patient selection: history of Graves' disease
Outcome: relapse within 2 years of stopping antithyroid drugs